Form 4 Filing for Bone Biologics Corp

Phillip Terry Meikle II, a director at Bone Biologics Corp, reported the acquisition of 113,896 non-employee stock options on September 28, 2026. These options, granted under the 2015 Equity Incentive Plan, have an exercise price of $0.50 and an expiration date of September 28, 2036. The options vest in four equal quarterly installments. Following this transaction, Mr. Meikle holds 113,896 shares of common stock underlying these options. The filing also details other option holdings with exercise prices of $5.28 and $11.28.